Home  |  Publications  |  Conferences   |  Join  |  Contact
                           
 
ISSN: 2167-1052

Advances in Pharmacoepidemiology & Drug Safety

Open Access
 
 
home » journals » advances-in-pharmacoepidemiology-drug-safety
 
 

Upcoming Special Issues

Special issue entitled: " A Focus on Drug Interactions" has been edited by
Editor Image
Department of Microbiology and Molecular Genetics
USA
 
 
 
University Logo
Special issue entitled: "Drug Discovery and ADMER of Drugs" has been edited by
Editor Image

Shufeng Zhou
Assoicate Dean
Department of Pharmaceutical Sciences
University of South Florida, USA
Tel: 813 974 6276, Fax: 813 905 9885
 

University Logo
Read More»
 

About the Journal

Advances in Pharmacoepidemiology & Drug Safety journal offers vital opportunities to researchers and scientist to explore the advanced and the latest research in the field of Pharmacoepidemiology and Drug Safety. This peer reviewed journal includes a wide range of fields like drug therapies, evaluation of drugs, effects, assessment of risk vs. benefit ratios in drug therapy, formulation and interpretation of regulatory guidelines, advancements in the drugs and therapeutic solutions and drug safety. Pharmacoepidemiology is a scholarly Open Access journal that aims to publish the most complete and reliable source of information in related fields.
Pharmacoepidemiology Journal strives to enhance the intelligence and information dissemination on topics closely related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety.The journal provides a unique forum dedicated to scientists to express their findings as research articles, review articles, case reports and short communications on an array of Pharmacoepidemiology and Drug Safety topics.Universally prominent Editorial Board members supervise the Peer Review process for Journal of Pharmacoepidemiology.
Pharmacoepidemiology journal’s impact factors is mainly calculated based on the number of articles published after the double blind peer review, essence of the work and the number of citations received for the published articles. Abstracts and full texts of all the articles published are freely accessible to everyone immediately after publication.
OMICS International is a leading Open Access publisher and scientific event organizer that take pride in welcoming the researchers and contributors across the globe to its 4th International Conference and Exhibition on Pharmacovigilance & Clinical Trials to be held during August 10-12, 2015 at London, UK.  
OMICS International organizes 300+ Conferences every year across USA, Europe & Asia in collaboration with more than 1000 scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Submit manuscript at http://editorialmanager.com/pharma/ or send as an e-mail attachment to the Editorial Office at editor.pds@omicsonline.org
Aims and Scope
 

Recently published articles

 
 
 
 
 
 
 
 
 
© 2008-2015 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version